Tag: withdrawal

Harmed patients are frequently unable to control the narrative of their own treatment and are subject to gaslighting, dangerous medical advice, and termination.

MIA's Richard Sears interviews psychotherapist Anne Guy about working with clients withdrawing from psychiatric drugs.

A new article discusses the lack of research dedicated to discontinuing psychiatric drugs and reviews existing strategies.

Adverse physiological symptoms of antidepressant withdrawal are regularly mistaken to be other problems to the detriment of the patient.

Online withdrawal forums document an assortment of risks associated with discontinuation of psychiatric drugs. Such information is readily available and must be disclosed during informed consent.

Online communities are stepping in to help people facing withdrawal effects amass information and receive support for their withdrawal experiences.

Protracted Withdrawal Syndrome characterized by long-term adverse experiences after coming off of antidepressants.

Sami Timimi provides a discussion of the ways medication may be helpful for some, and advice and information on discontinuing psychiatric drugs.

A new study looks at how online communities provide information and support for patients experiencing psychiatric drug withdrawal.

Patient advocates join with researchers and service users to present first-hand experiences of antidepressant withdrawal.

“My life was very, very good.” That’s how Michael sums up how things were for him—prior to his suffering from devastating withdrawal effects after discontinuing GlaxoSmithKline’s blockbuster drug Paxil.

Medically-induced harm—affecting tens of millions of people worldwide—has taken the field decades to take seriously.

Researchers review a new synthesis of the existing evidence and conclude that the harms of antidepressants outweigh any benefits.

New strategies for tapering psychiatric drugs achieved by acknowledging withdrawal symptoms and valuing service-users’ first-hand knowledge.

Trials of antidepressants for relapse prevention are confounded by withdrawal effects caused by the drugs.

After suffering PTSD in the late 1980s, I reluctantly accepted antidepressants. In time, I had resolved the trauma, but when I tried to stop the antidepressants (Prozac, and later Zoloft), I assumed my desperate feelings and “return” of depression were an indication I had an imbalance and needed those drugs. I didn’t understand I was experiencing withdrawal. (I was never told that for most people, psychiatric medications need to be tapered.)

Recent claims about antidepressant effectiveness have been based on misleading statements and misunderstandings of the science.

Researchers examine how rapid discontinuation can mimic the relapse of mental health symptoms and confound psychiatric drug studies.

A new article in Lancet Psychiatry finds that slower tapering of SSRIs is better for preventing antidepressant withdrawal effects.

An international group of researchers, including several with financial ties to manufacturers of antidepressants, explore possible explanations for why long-term users of antidepressants become chronically depressed.

Psychiatrist and psychologist outline pharmacological and psychotherapeutic strategies for discontinuing antidepressants.

Mixed-Methods study explores the experiences of antipsychotic discontinuation among service users.

New research suggests that clinicians should exercise caution prescribing SNRIs as first-line treatment for mood and anxiety disorders.

Prominent researchers conduct a review of antidepressant withdrawal incidence, duration, and severity. Results lead to call for new clinical guidelines.

Findings point to the role of withdrawal symptoms and prescriber practices in long-term antidepressant use.